Fred Hutchinson
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma
Hope vs Hype: Managing Patient Expectations for CAR T-Cell Therapy
HA-1 T TCR T Cell Immunotherapy for the Treating of Patients with Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Cameron Turtle Receives Fred Hutch’s Endowed Chair for Immunotherapy
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
The Leukemia & Lymphoma Society awards $13.8 million for research into pediatric blood cancers
Seattle Cancer Care Alliance opens its doors to share its cellular therapy experience

The Seattle Cancer Care Alliance, the clinical care partner of the Fred Hutchinson Cancer Research Center, has been at the forefront of cellular therapies for cancer treatment since the field emerged. It was there where E. Donnall Thomas, MD, and his team pioneered the use of bone marrow transplant during the 1970s and SCCA’s position remains unchanged in the field of cellular therapies as its research and clinical staff have administered more CAR T-cell therapies to patients than any other facility in the world.
Human herpesvirus 6B linked to increased mortality among certain HSCT recipients

Detection of human herpesvirus 6B in bronchoalveolar lavage fluid appeared associated with higher risk for mortality among allogeneic hematopoietic stem cell transplant recipients with lower respiratory tract disease, according to results of a retrospective, single-center study published in Journal of Clinical Oncology.
Expense reimbursement model aims to ‘level playing field’ for clinical trial participation
Patients lack understanding of genomic results in Lung-MAP study

BARCELONA — Many participants in the Lung-MAP biomarker-driven clinical trial lacked understanding of genomic test results despite indicating they had adequate information on the benefits and risks of trial enrollment, according to study results presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer.